DE:0T20 / Traws Pharma, Inc. - Net Long/Short Value

Traws Pharma, Inc.
DE ˙ DB
DE:0T20 / Traws Pharma, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Geode Capital Management, Llc
Northwestern Mutual Wealth Management Co
Vanguard Fiduciary Trust Co
Adage Capital Partners Gp, L.l.c.
Boothbay Fund Management, Llc
Fmr Llc
Royal Bank Of Canada
Squadron Capital Management LLC
UBS Group AG
Jones Financial Companies Lllp
Cassaday & Co Wealth Management LLC
Vanguard Capital Management Llc
Morgan Stanley
Lynx1 Capital Management LP
Palumbo Wealth Management LLC
Dauntless Investment Group, LLC
ADAR1 Capital Management, LLC
Jane Street Group, Llc
State Street Corp
BlackRock, Inc.
Vanguard Global Advisers, LLC
Tower Research Capital LLC (TRC)
Vanguard Group Inc
Caitong International Asset Management Co., Ltd
SBI Securities Co., Ltd.
Orbimed Advisors Llc
Two Sigma Investments, Lp
Ikarian Capital, LLC
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:TRAW 1,37 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista